Cite

HARVARD Citation

    Reed, J. et al. (2019). Developments in the use of tyrosine kinase inhibitors in the treatment of renal cell carcinoma. Expert review of anticancer therapy. 19 (3), pp. 259-271. [Online]. 
  
Back to record